ZLABZai Lab Limited
Slide 1 of 3
Company Overview
Name
Zai Lab Limited
52W High
$44.34
52W Low
$20.13
Market Cap
$30B
Dividend Yield
0%
Price/earnings
-0.03
P/E
-0.03
Tags
Dividends
No dividend
Sentiment
Score
Bullish
73
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$116.1M
Operating Revenue
$116.1M
Total Gross Profit
$69.2M
Total Operating Income
$-48.8M
Net Income
$-36M
EV to EBITDA
$0.00
EV to Revenue
$66.44
Price to Book value
$39.42
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$70.1M
Research & Development Expense
$47.9M
Total Operating Expenses
$-118M
Interest Expense
$-1.4M
Interest & Investment Income
$8.3M
Other Income / (Expense), net
$5.9M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Zai Lab Limited
52W High
$44.34
52W Low
$20.13
Market Cap
$30B
Dividend Yield
0%
Price/earnings
-0.03
P/E
-0.03
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Bullish
73
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$116.1M
Operating Revenue
$116.1M
Total Gross Profit
$69.2M
Total Operating Income
$-48.8M
Net Income
$-36M
EV to EBITDA
$0.00
EV to Revenue
$66.44
Price to Book value
$39.42
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$70.1M
Research & Development Expense
$47.9M
Total Operating Expenses
$-118M
Interest Expense
$-1.4M
Interest & Investment Income
$8.3M
Other Income / (Expense), net
$5.9M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Ying Du
Location
N/A, China
Exchange
Nasdaq
Website
https://zailaboratory.com
Summary
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience.
Company Info
CEO
Ying Du
Location
N/A, China
Exchange
Nasdaq
Website
https://zailaboratory.com
Summary
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience.
